1. Oncogenic KRAS provides a uniquely powerful and variable oncogenic contribution among RAS family members in the colonic epithelium. Keller JW, Franklin JL, Graves-Deal R, Friedman DB, Whitwell CW, Coffey RJ (2007) J Cell Physiol 210(3): 740-9
    › Primary publication · 17133351 (PubMed)
  2. Naked2 acts as a cargo recognition and targeting protein to ensure proper delivery and fusion of TGF-alpha containing exocytic vesicles at the lower lateral membrane of polarized MDCK cells. Li C, Hao M, Cao Z, Ding W, Graves-Deal R, Hu J, Piston DW, Coffey RJ (2007) Mol Biol Cell 18(8): 3081-93
    › Primary publication · 17553928 (PubMed) · PMC1949375 (PubMed Central)
  3. Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. Coffey RJ, Washington MK, Corless CL, Heinrich MC (2007) J Clin Invest 117(1): 70-80
    › Primary publication · 17200708 (PubMed) · PMC1716220 (PubMed Central)
  4. Lrp6 is required for convergent extension during Xenopus gastrulation. Tahinci E, Thorne CA, Franklin JL, Salic A, Christian KM, Lee LA, Coffey RJ, Lee E (2007) Development 134(22): 4095-106
    › Primary publication · 17965054 (PubMed) · PMC4428168 (PubMed Central)
  5. Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Johnson JC, Schmidt CR, Shrubsole MJ, Billheimer DD, Joshi PR, Morrow JD, Heslin MJ, Washington MK, Ness RM, Zheng W, Schwartz DA, Coffey RJ, Beauchamp RD, Merchant NB (2006) Clin Gastroenterol Hepatol 4(11): 1358-65
    › Primary publication · 16996805 (PubMed)
  6. Structural studies of human Naked2: a biologically active intrinsically unstructured protein. Hu T, Krezel AM, Li C, Coffey RJ (2006) Biochem Biophys Res Commun 350(4): 911-5
    › Primary publication · 17045239 (PubMed) · PMC1661664 (PubMed Central)
  7. Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma. Rothenberg ML, LaFleur B, Levy DE, Washington MK, Morgan-Meadows SL, Ramanathan RK, Berlin JD, Benson AB, Coffey RJ (2005) J Clin Oncol 23(36): 9265-74
    › Primary publication · 16361624 (PubMed)
  8. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Means AL, Meszoely IM, Suzuki K, Miyamoto Y, Rustgi AK, Coffey RJ, Wright CV, Stoffers DA, Leach SD (2005) Development 132(16): 3767-76
    › Primary publication · 16020518 (PubMed)
  9. Mtgr1 is a transcriptional corepressor that is required for maintenance of the secretory cell lineage in the small intestine. Amann JM, Chyla BJ, Ellis TC, Martinez A, Moore AC, Franklin JL, McGhee L, Meyers S, Ohm JE, Luce KS, Ouelette AJ, Washington MK, Thompson MA, King D, Gautam S, Coffey RJ, Whitehead RH, Hiebert SW (2005) Mol Cell Biol 25(21): 9576-85
    › Primary publication · 16227606 (PubMed) · PMC1265807 (PubMed Central)
  10. Lysophosphatidic acid, a disintegrin and metalloprotease-17 and heparin-binding epidermal growth factor-like growth factor in ovarian cancer: the first word, not the last. Braun AH, Coffey RJ (2005) Clin Cancer Res 11(13): 4639-43
    › Primary publication · 16000554 (PubMed)